Skip to main content
. Author manuscript; available in PMC: 2014 Mar 28.
Published in final edited form as: Eur J Cancer Prev. 2011 Sep;20(5):396–402. doi: 10.1097/CEJ.0b013e3283463943

Figure 4.

Figure 4

Association of CD44 polymorphisms with patient age and tumor size at breast cancer diagnosis. The ages were compared at breast cancer diagnosis between Group I and Group II patients from all (A), Caucasian American (C) and African American (E) female breast cancer patients as well as the tumor sizes at breast cancer diagnosis between Group I and Group II patients from all (B), Caucasian American (D) and African American (F) female breast cancer patients. Group I patients are those female breast cancer patients who did not have the CD44 polymorphisms whereas Group II patients are those with CD44 polymorphisms in CD44 exon2 coding sequence as shown in Fig. 2A. Wilcoxon-Mann-Whitney test was used to determine the statistical differences in the age of patients and tumor sizes between two groups.